BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33749163)

  • 1. Identification of an individualized RNA binding protein-based prognostic signature for diffuse large B-cell lymphoma.
    Xie Y; Luo X; He H; Pan T; He Y
    Cancer Med; 2021 Apr; 10(8):2703-2713. PubMed ID: 33749163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer.
    Chen F; Wang Q; Zhou Y
    BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potential panel of six-long non-coding RNA signature to improve survival prediction of diffuse large-B-cell lymphoma.
    Sun J; Cheng L; Shi H; Zhang Z; Zhao H; Wang Z; Zhou M
    Sci Rep; 2016 Jun; 6():27842. PubMed ID: 27292966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel NET-related gene signature for predicting DLBCL prognosis.
    Shi H; Pan Y; Xiang G; Wang M; Huang Y; He L; Wang J; Fang Q; Li L; Liu Z
    J Transl Med; 2023 Sep; 21(1):630. PubMed ID: 37716978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integral Analysis of the RNA Binding Protein-associated Prognostic Model for Renal Cell Carcinoma.
    Qin X; Liu Z; Yan K; Fang Z; Fan Y
    Int J Med Sci; 2021; 18(4):953-963. PubMed ID: 33456353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OSdlbcl: An online consensus survival analysis web server based on gene expression profiles of diffuse large B-cell lymphoma.
    Dong H; Wang Q; Zhang G; Li N; Yang M; An Y; Xie L; Li H; Zhang L; Zhu W; Zhao S; Zhang H; Guo X
    Cancer Med; 2020 Mar; 9(5):1790-1797. PubMed ID: 31918459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of the prognostic implication and immune infiltration of CISD2 in diffuse large B-cell lymphoma.
    Zhang C; Lin Q; Li C; Qiu Y; Chen J; Zhu X
    Front Immunol; 2023; 14():1277695. PubMed ID: 38155967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated prognosis model of pharmacogenomic gene signature and clinical information for diffuse large B-cell lymphoma patients following CHOP-like chemotherapy.
    Hu J; Xu J; Yu M; Gao Y; Liu R; Zhou H; Zhang W
    J Transl Med; 2020 Mar; 18(1):144. PubMed ID: 32228625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA Binding Protein-Based Model for Prognostic Prediction of Colorectal Cancer.
    Li T; Hui W; Halike H; Gao F
    Technol Cancer Res Treat; 2021; 20():15330338211019504. PubMed ID: 34080453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
    Huang QR; Li JW; Pan XB
    Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction significance of autophagy-related genes in survival probability and drug resistance in diffuse large B-cell lymphoma.
    Xiong D; Wei X; Huang W; Zheng J; Feng R
    Aging (Albany NY); 2024 Jan; 16(2):1049-1076. PubMed ID: 38240686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 6-lncRNA signature predicts prognosis of diffuse large B-cell lymphoma.
    Gao H; Wu B; Jin H; Yang W
    J Biochem Mol Toxicol; 2021 Jun; 35(6):1-12. PubMed ID: 33710713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Model of Tumor-Infiltrating B Lymphocyte Specific RNA-Binding Protein-Related Genes With Potential Prognostic Value and Therapeutic Targets in Multiple Myeloma.
    Zhang J; He P; Wang X; Wei S; Ma L; Zhao J
    Front Genet; 2021; 12():778715. PubMed ID: 34976013
    [No Abstract]   [Full Text] [Related]  

  • 14. [Screening of Differential Expression Autophagy Genes Related to the Prognosis of Diffuse Large B-Cell Lymphoma and Establishment of an Autophagy Model].
    Zhang JD; Zhang HM; Lu D; Wang ZN; Chen HR; Lu XC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1101-1108. PubMed ID: 35981368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High PPP4C expression predicts poor prognosis in diffuse large B-cell lymphoma.
    Hui X; Li L; Xiong W; Liu Y; Li H; Zhang H; Zhao S; Zhang Y
    Clin Exp Med; 2024 Apr; 24(1):89. PubMed ID: 38683255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment.
    Liang XJ; Fu RY; Wang HN; Yang J; Yao N; Liu XD; Wang L
    J Immunol Res; 2021; 2021():5564568. PubMed ID: 34212052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome profiling reveals an integrated mRNA-lncRNA signature with predictive value for long-term survival in diffuse large B-cell lymphoma.
    Gao Q; Li Z; Meng L; Ma J; Xi Y; Wang T
    Aging (Albany NY); 2020 Nov; 12(22):23275-23295. PubMed ID: 33221755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel RNA-Binding Protein-Based Nomogram for Predicting Survival of Patients with Gastric Cancer.
    Zhu M; Cai J; Wu Y; Wu X; Feng L; Yin Z
    Med Sci Monit; 2021 Jan; 27():e928195. PubMed ID: 33471782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma.
    Yan J; Yuan W; Zhang J; Li L; Zhang L; Zhang X; Zhang M
    Front Endocrinol (Lausanne); 2022; 13():846357. PubMed ID: 35498426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score.
    Tekin N; Omidvar N; Morris TP; Conget P; Bruna F; Timar B; Gagyi E; Basak R; Naik O; Auewarakul C; Sritana N; Levy D; Cerci JJ; Bydlowski SP; Pereira J; Dimamay MP; Natividad F; Chung JK; Belder N; Kuzu I; Paez D; Dondi M; Carr R; Ozdag H; Padua RA
    Oncotarget; 2016 Dec; 7(50):83319-83329. PubMed ID: 27825111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.